Revision: Dec. 6, 2023, 1:20 p.m.
HB 1349-FN - AS INTRODUCED
2024 SESSION
24-2196
02/05
HOUSE BILL 1349-FN
SPONSORS: Rep. H. Howard, Straf. 4; Rep. Vail, Hills. 6; Rep. A. Murray, Hills. 20; Rep. Newell, Ches. 4; Rep. Seibert, Hills. 21; Rep. T. Mannion, Hills. 1
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
ANALYSIS
This bill adds generalized anxiety disorder as a qualifying medical condition for the use of therapeutic cannabis.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
24-2196
02/05
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Subparagraph; Use of Cannabis for Therapeutic Purposes; Qualifying Medical Condition; Generalized Anxiety Disorder. Amend RSA 126-X:1, IX(b) by inserting after subparagraph (6) the following new subparagraph:
(7) Generalized anxiety disorder.
2 Effective Date. This act shall take effect 60 days after its passage.
24-2196
11/6/23
HB 1349-FN- FISCAL NOTE
AS INTRODUCED
FISCAL IMPACT: [ X ] State [ ] County [ ] Local [ ] None
|
| |||||
Estimated State Impact - Increase / (Decrease) | ||||||
| FY 2024 | FY 2025 | FY 2026 | FY 2027 | ||
Revenue | $0 | $0 | $0 | $0 | ||
Revenue Fund(s) | Application and fee revenue under RSA 126-X, relative to the use of cannabis for therapeutic purposes | |||||
Expenditures | $0 | $0 | $0 | $0 | ||
Funding Source(s) | Application and fee revenue under RSA 126-X, relative to the use of cannabis for therapeutic purposes
| |||||
Appropriations | $0 | $0 | $0 | $0 | ||
Funding Source(s) | None
| |||||
• Does this bill provide sufficient funding to cover estimated expenditures? [X] Yes • Does this bill authorize new positions to implement this bill? [X] No | ||||||
METHODOLOGY:
This bill adds generalized anxiety disorder to the definition of "qualifying medical condition" for the purposes of the use of cannabis for therapeutic purposes law. The Department of Health and Human Services indicates addition of this qualifying medical condition may result in more patients eligible for the Therapeutic Cannabis Program. To the extent additional patients apply to the program, there would be an increase in application fee revenue received by the Department. Though indeterminable, the Department estimated revenue may increase up to $35,500 a year assuming 710 individuals with anxiety disorder pay the $50 application for the program. Under the statutorily mandated self-funding structure of the Therapeutic Cannabis Program in RSA 126-X and the fee structure established in administrative rule, this may result in lower annual registration fees for the Alternative Treatment Centers. There would be an increase in the number of applications processed by the Department, however it is not expected that the increase would necessitate additional staff.
AGENCIES CONTACTED:
Department of Health and Human Services